-
公开(公告)号:US11813233B2
公开(公告)日:2023-11-14
申请号:US16336294
申请日:2017-09-29
申请人: NESTEC S.A.
发明人: Claus Rieker , Julie Hudry-Labbe , Jeroen Antonius Johannes Schmitt , Corina Boschat , Yvonne Beata Silber
IPC分类号: A61K31/202 , A61K31/197 , A61K31/519 , A61K31/14 , A61K31/714 , A61K31/198 , A61K31/4415 , A61K31/17 , A61K31/375 , A61K31/4406 , A61K33/00 , A61K31/341 , A61K31/355 , A61K31/4188 , A61K31/455 , A61K31/51 , A61K31/525 , A61K31/59 , A61K31/675 , A61K33/04
CPC分类号: A61K31/714 , A61K31/14 , A61K31/17 , A61K31/197 , A61K31/198 , A61K31/202 , A61K31/341 , A61K31/355 , A61K31/375 , A61K31/4188 , A61K31/4406 , A61K31/4415 , A61K31/455 , A61K31/51 , A61K31/519 , A61K31/525 , A61K31/59 , A61K31/675 , A61K33/00 , A61K33/04 , A61K31/202 , A61K2300/00 , A61K31/4415 , A61K2300/00 , A61K31/519 , A61K2300/00 , A61K31/198 , A61K2300/00 , A61K31/714 , A61K2300/00
摘要: A method of attenuating, treating or preventing cognitive aging in an individual who does not have dementia includes administering to the individual a therapeutically effective amount of a composition containing an omega-3 fatty acid and choline. The method can achieve a benefit that is one or more of decreasing brain atrophy, increasing or maintaining number of synapses, increasing amyloid-β phagocytosis, or decreasing or maintaining neuroinflammation in the non-demented individual. The method can prevent dementia in an individual at risk thereof, for example an elderly human. The composition can be administered to the individual in a daily dose that provides 5.5 mg/day to 5,500 mg/day of the choline, for example 85 mg/day to 3,500 mg/day of the choline.
-
公开(公告)号:US11684204B2
公开(公告)日:2023-06-27
申请号:US15531098
申请日:2015-11-26
申请人: NESTEC S.A.
发明人: Da Mi Byun , Bertrand Guyon , Marco Magatti
CPC分类号: A47J31/46 , A47J31/3623 , A47J31/60
摘要: A machine (1) for dispensing a dispensable liquid (5) has: a liquid delivery module (10) for delivering the dispensable liquid (5) from a source (50) and a service area (7) for collecting collectable liquid (5′) from the liquid delivery module (10). The machine further includes a directing device (20) that has a dispensing position for directing said dispensable liquid (5) from the delivery module (10) to a dispensing area (6) and a collecting position for directing collectable liquid (5′) from the delivery module (10) to the service area (7). The directing device (20) has only one evacuation portion (21) from which: —the dispensable liquid (5) is evacuated from the directing device (20) to the dispensing area (6) when the directing device (20) is in the dispensing position; and—the collectable liquid (5′) is evacuated to the service area (7) when the directing device (20) is in the collecting position.
-
公开(公告)号:US11678772B2
公开(公告)日:2023-06-20
申请号:US16462713
申请日:2017-12-11
申请人: NESTEC S.A.
IPC分类号: A47J43/00 , A47J43/046 , A47J43/08 , B01F33/453 , B01F101/07
CPC分类号: A47J43/0465 , A47J43/085 , B01F33/453 , B01F2101/07
摘要: A machine (1) for processing a liquid food substance incorporates: a container (10) delimiting a cavity (10′) for containing said liquid food substance; an impeller (20) for driving the liquid food substance in the container (10); a motor (30) for driving the impeller (20); a motor chamber (40) for containing the motor (30); and a means for evacuating heat from the motor chamber (40). Such means comprises one or more movable members (50) that are driven by the motor (30) and that are configured to circulate air (2a,2b) in the motor chamber (40) to evacuate heat therefrom.
-
公开(公告)号:US11602154B2
公开(公告)日:2023-03-14
申请号:US15189509
申请日:2016-06-22
申请人: NESTEC S.A.
发明人: Xiaoping Fu , Alexander Sher , Winnie Octavia , Dominick Damiano , Ken Erickson , Richard Nelson , David Eckerle , Madansinh Vaghela
IPC分类号: A23C11/00
摘要: Natural Creamers for providing whitening and indulgent texture/mouthfeel of beverage and food products are provided. The creamers have long-term stability, high whitening capacity and a pleasant mouthfeel when added to beverage and food, while being free from artificial additives. In a general embodiment, the present disclosure provides a creamer comprising added sugar, milk fat, milk proteins and optionally natural flavors and free of any artificial additives. Wherein the ratio of milk fat:milk protein is less than 5.3:1; and wherein the Lumisizer instability index of liquid creamer is less than 10.
-
公开(公告)号:US11533941B2
公开(公告)日:2022-12-27
申请号:US16331589
申请日:2017-09-13
申请人: NESTEC S.A.
发明人: Anne Thevenier , Susanne Schuh , Katja Johnson , Martin Vikas , Martinas Kuslys , Rinat Ran-Ressler , Koraljka Rade-Kukic
IPC分类号: A23L33/185 , A23L33/00 , A23L33/135 , A23C11/06 , A23L33/115 , A23L19/12 , A23C9/123
摘要: A nutritional composition obtainable by fermenting a mixture comprising protein, carbohydrate and fat, wherein the major source of protein is potato protein, and wherein the mixture is fermented by lactic acid-producing bacteria.
-
公开(公告)号:US11484036B2
公开(公告)日:2022-11-01
申请号:US16301653
申请日:2017-05-16
申请人: NESTEC S.A.
发明人: Yvette Fleury Rey , Christina Vafeiadi , Stephane Duboux , Catherine Ngom-Bru , Cassandra Mokdad , Clementine Tastet , Christof Gysler , Carl Erik Hansen
摘要: The present invention relates to flavour generation. In particular the invention relates to a method for flavour generation in a heat-treated food product using a prolidase enzyme. The invention also relates to a heat-treated food product prepared according to the method of the invention.
-
公开(公告)号:US11478010B2
公开(公告)日:2022-10-25
申请号:US15327745
申请日:2015-07-20
申请人: NESTEC S.A.
IPC分类号: A23L29/225 , A23L33/00 , A23L29/269 , A23L7/10 , A61K47/36 , A23L33/10 , A23L2/52
摘要: Nutritional products, uses thereof, methods for the manufacture and methods for improving the cohesiveness of the nutritional products are disclosed. The nutritional products have improved cohesiveness for promoting safer swallowing of food boluses for individuals having swallowing difficulties such as dysphagia.
-
公开(公告)号:US11419885B2
公开(公告)日:2022-08-23
申请号:US16437454
申请日:2019-06-11
申请人: NESTEC S.A.
IPC分类号: A61K31/702 , A61K45/06 , A61K35/741 , A23L33/00 , A61K9/00 , A61K35/00
摘要: A composition contains at least one fucosylated oligosaccharide, for use in preventing and/or treating a URT infection in an infant or young child fulfilling at least one of the following criteria: i) the infant or young child is born from a non-secretor mother and/or is fed with a mother's milk deficient in at least one fucosylated oligosaccharide, ii) the infant or young child has at least one sibling, and iii) the infant or young child was born by C-section.
-
公开(公告)号:US11406650B2
公开(公告)日:2022-08-09
申请号:US15504916
申请日:2015-08-04
申请人: NESTEC S.A.
IPC分类号: A61K31/702 , A23L5/00 , A23L33/125 , A23L29/30 , A23L33/00 , A23L33/135 , A23L33/21 , A23L33/19 , A61K35/745
摘要: The invention proposes a nutritional composition comprising selected oligosaccharides that reduces the abundance of Streptococcus bacteria in the gut of infants or young mammals. The infants are preferably infants in needs presenting a relatively high count of Streptococcus. Ultimately the reduction of streptococcus and the related microbiota balance affects and lowers the risk of adiposity or obesity later in life.
-
公开(公告)号:US11369646B2
公开(公告)日:2022-06-28
申请号:US15521977
申请日:2015-10-29
申请人: NESTEC S.A.
发明人: Clara Lucia Garcia-Rodenas , Bernard Berger , Catherine Ngom-Bru , Melissa Lepage , Tara Neville
IPC分类号: A61K35/747 , A23L33/00 , A23L33/135 , A61K35/745 , A61K31/702 , A61K31/733 , A61K45/06 , A61K9/00
摘要: The invention concerns Lactobacillus reuteri for use in the prevention or treatment of microbiota dysbiosis, in particular, decreased levels of Actinobacteria and increased levels of Proteobacteria, in young mammals and in the prevention or treatment of disorders associated therewith. The microbiota dysbiosis may have been cause by numerous factors including being born by caesarean section, exposure to antibiotics in utero or after birth, or, parenteral feeding, hospitalizing, psychological stress or by gastrointestinal dysfunctions. The disorders that may be treated or prevented by preventing or treating microbiota dysbiosis include propensity to infection, allergy, type I diabetes mellitus, insulin resistance, type 2 diabetes, celiac disease, peripheral and central adiposity, obesity, necrotizing enterocolitis, inflammatory bowel disease, such as Crohn's disease and ulcerative colitis, and functional gastrointestinal disorders such as IBS, functional diarrhea, functional constipation, recurrent abdominal pain, and dyspepsia.
-
-
-
-
-
-
-
-
-